Before the Basket: A Shopper's Compliance Audit of UK CBD Novel Food Status

Most CBD buying guides begin with milligrams and end with certificates of analysis. Both matter, and this publication has examined them at length. But there is an earlier question that deserves the shopper's attention first: does the product sit within the UK's novel food framework at all? A vial can be pure, potent and beautifully labelled while still resting on a regulatory footing that is, at best, unresolved. That is a consumer rights matter before it is a quality matter.

Why the novel food question comes first

CBD extracted and purified for use in food and food supplements has been treated in the UK as a novel food. The reasoning is historical and straightforward: the ingredient did not have a significant history of consumption in this form before May 1997, the cut-off date that anchors the novel food regime. From 2019 onwards the Food Standards Agency required businesses to submit applications for authorisation, and in early 2021 it began publishing a public list of products linked to applications that had progressed far enough to be considered. That list has been revised repeatedly since, with entries added, queried and in some cases removed.

The practical consequence for a buyer in 2026 is this: the list is not a guarantee of safety, still less an endorsement of quality, but its absence is a meaningful signal. A product with no traceable position on it invites questions the shopper is entitled to ask before parting with money.

What the public list is, and what it is not

The list is best understood as a register of applications in progress. Inclusion indicates that a business has submitted an application that the regulator has accepted onto the list, and that the product identity has been recorded. It does not signify that the application has been fully assessed or authorised, and it does not certify purity, potency or label accuracy. Nor does it remove the need for the batch-level testing documents we have discussed elsewhere.

Treat it instead as the first gate. Passing through it does not make a product good. Failing to appear at all makes the product considerably harder to justify.

Reading the trail: label, batch and retailer page

A credible compliance trail is rarely found in one place. It is assembled from three sources, and they should agree with one another.

The label. Look for the business name and a UK address, a batch or lot code, a best-before date and a clear statement of cannabidiol content per container and per serving. The named business should be identifiable and contactable, not a postbox in a jurisdiction that makes redress impractical.

The batch documentation. A certificate of analysis should correspond to the batch code on the pack, not to a generic product line. Where a retailer publishes a certificate, check that the laboratory named is independent and that the report date is recent enough to be meaningful for the stock being sold.

The retailer page. This is where the compliance trail most often frays. A responsible retailer will identify the business responsible for the product, describe its novel food position in plain terms and avoid implying that listing equals approval. Vague references to being "fully compliant" without any named entity or reference point should be read as decoration rather than evidence.

Where the trail commonly breaks

Certain patterns recur often enough to be worth naming.

• The retailer describes the product as "approved" or "authorised" without distinguishing between an application on the public list and a completed authorisation.
• The named business on the label differs from the business named on the retailer page, and neither can be reconciled with the entry on the list.
• Therapeutic claims appear \u2014 claims to treat, cure or prevent a condition. These are not permitted for food supplements, and their presence tends to indicate a broader looseness with regulatory detail.
• The novel food position is addressed only in response to a direct enquiry, or not at all.
• The batch code on the certificate does not match the batch code on the pack, or no batch code is given.

None of these observations is conclusive on its own. Taken together, they describe a business that has not done the unglamorous work of documentation.

What a sound compliance posture looks like

A well-documented product tends to feel unremarkable. The label names a real business. The batch code matches. The certificate is dated and specific. The retailer page states the novel food position without overclaiming, and a question sent to the contact address receives a straightforward answer within a reasonable time. There is no theatre about it, and that is rather the point.

Shoppers should also expect honesty about limits. A credible seller will say that inclusion on the public list reflects an application in progress, that testing documents describe a specific batch, and that neither substitutes for medical advice. Evasiveness about these limits is itself informative.

A pre-purchase audit checklist

Before completing a purchase in 2026, a shopper can work through the following in ten minutes.

1. Search the public novel food list for the business name and the product name as they appear on the label.
2. Confirm the business named on the label matches the business named on the retailer page and, where applicable, on the list.
3. Check that the pack carries a batch or lot code and a best-before date.
4. Request or locate a certificate of analysis and confirm the batch code matches.
5. Confirm the laboratory is independent and the report is recent.
6. Read the marketing copy for therapeutic claims, and treat any found as a warning sign.
7. Look for a UK contact address and a functioning enquiries channel.
8. Note whether the retailer distinguishes between listing and authorisation, or blurs the two.
9. Ask one direct question about novel food status and observe the quality of the reply.
10. Record what you found, so that a later problem can be evidenced rather than argued.

A closing note on proportion

Compliance paperwork is not the most exciting part of choosing a CBD product, and it is not a substitute for the purity, potency and routine questions this site returns to. It is, however, the floor beneath them. A product that cannot be traced to a named business with a documented position is a product whose other claims deserve correspondingly greater scrutiny. Shoppers who begin with the shelf rather than the slogan tend to waste less money and encounter fewer disappointments.

This article offers consumer guidance only. It is not legal advice, and readers with a specific dispute or regulatory question should seek appropriate professional support or contact the relevant authority directly.